U.S. SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended ~~June~~September 30, 2017

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ________ to ________

Commission file number 000-54479

Trenton Acquisition Corp.

(Exact name of registrant as specified in its charter)

Delaware		45-2558944
(State or other jurisdiction of		(I.R.S. Employer
incorporation or organization)		Identification Number)

430 Park Avenue 4^th Floor

New York, NY 10022

(Address of principal executive offices) (Zip Code)

(212) 356-0509

(Registrant’s telephone number, including area code)

(Former name, former address and former fiscal year, if changed since last report)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐.

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate website, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act:

Large accelerated filer ☐	Accelerated filer ☐
Non-accelerated filer ☐ (Do not check if a smaller reporting company)	Smaller reporting company ☒
Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☒ No ☐.

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date: 9,250,000 shares of common stock, par value $.0001 per share, outstanding as of ~~August~~October 1112, 2017.

TRENTON ACQUISITION CORP.

TABLE OF CONTENTS

		Page
PART I - FINANCIAL INFORMATION:
Item 1.	Financial Statements:	1
	Condensed Balance Sheets as of June 30, 2017 (Unaudited) and March 31, 2017	1
	Condensed Balance Sheets as of September 30, 2017 (Unaudited) and March 31, 2017	1
	Condensed Statements of Operations (Unaudited) for the Three Months Ended June 30, 2017 and 2016	2
	Condensed Statements of Operations (Unaudited) for the Three and Six Months Ended September 30, 2017 and 2016	2
	Condensed Statements of Cash Flows (Unaudited) for the Three Months Ended June 30, 2017 and 2016	3
	Condensed Statements of Cash Flows (Unaudited) for the Six Months Ended September 30, 2017 and 2016	3
	Notes to Condensed Financial Statements	4
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	8
Item 3.	Quantitative and Qualitative Disclosures About Market Risk	12
Item 4.	Controls and Procedures	12
PART II - OTHER INFORMATION:
Item 1.	Legal Proceedings	12
Item 1A.	Risk Factors	12
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	12
Item 3.	Defaults Upon Senior Securities	12
Item 4.	Mine Safety Disclosures	12
Item 5.	Other Information	12
Item 6.	Exhibits	13
Signatures		14

FORWARD-LOOKING STATEMENTS

Certain statements made in this Quarterly Report on Form 10-Q are “forward-looking statements” regarding the plans and objectives of management for future operations and market trends and expectations. Such statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. The forward-looking statements included herein are based on current expectations that involve numerous risks and uncertainties. Our plans and objectives are based, in part, on assumptions involving the continued expansion of our business. Assumptions relating to the foregoing involve judgments with respect to, among other things, future economic, competitive and market conditions and future business decisions, all of which are difficult or impossible to predict accurately and many of which are beyond our control. Although we believe that our assumptions underlying the forward-looking statements are reasonable, any of the assumptions could prove inaccurate and, therefore, there can be no assurance that the forward-looking statements included in this report will prove to be accurate. In light of the significant uncertainties inherent in the forward-looking statements included herein, the inclusion of such information should not be regarded as a representation by us or any other person that our objectives and plans will be achieved. We undertake no obligation to revise or update publicly any forward-looking statements for any reason. The terms “we”, “our”, “us”, or any derivative thereof, as used herein refer to Trenton Acquisition Corp, a Delaware corporation.

PART I - FINANCIAL INFORMATION

Item 1. Financial Statements.

TRENTON ACQUISITION CORP.

CONDENSED BALANCE SHEETS

	June 30, 2017			March 31, 2017
	September 30, 2017			March 31, 2017
	(UNAUDITED)			(AUDITED)
ASSETS
CURRENT ASSETS:
Cash	$	~~497~~3,851		$	692
Total Current Assets		~~497~~3,851			692
TOTAL ASSETS	$	~~497~~3,851		$	692
LIABILITIES AND STOCKHOLDERS’ DEFICIENCY
CURRENT LIABILITIES:
Accounts payable and accrued expenses	$	4,000		$	-
Loan payable - related party	$	82,000		$	85,000
Loans payable - related parties		37,000			85,000
Total Current Liabilities		82,000			85,000
Total Current Liabilities		41,000			85,000
COMMITMENTS AND CONTINGENCIES
STOCKHOLDERS’ DEFICIENCY:
Preferred stock, $.0001 par value; 10,000,000 shares authorized; none issued and outstanding		-			-
Common stock, $.0001 par value; 100,000,000 shares authorized; 9,250,000 and 5,000,000 shares issued and outstanding, respectively		925			500
Additional paid-in capital		215,025			130,450
Accumulated deficit		(~~256~~294,~~453~~099	)		(215,258	)
Total Stockholders’ Deficiency		(4078,~~503~~149	)		(84,308	)
TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIENCY	$	~~497~~3,851		$	692

See accompanying notes to the condensed financial statements

TRENTON ACQUISITION CORP.

CONDENSED STATEMENTS OF OPERATIONS

(Unaudited)

	Three Months Ended			Three Months Ended			Six Months Ended			Six Months Ended
	June 30, 2017			June 30, 2016
	September 30, 2017			September 30, 2016			September 30, 2017			September 30, 2016
REVENUES	$	-		$	-		$	-		$	-
GENERAL AND ADMINISTRATIVE EXPENSES		4137,~~195~~646			1016,~~676~~152			78,841			26,828
(LOSS) BEFORE BENEFIT FROM INCOME TAXES		(4137,~~195~~646	)		(1016,~~676~~152	)		(78,841	)		(26,828	)
BENEFIT FROM INCOME TAXES		-			-			-			-
NET (LOSS)	$	(4137,~~195~~646	)	$	(1016,~~676~~152	)	$	(78,841	)	$	(26,828	)
BASIC AND DILUTED (LOSS) PER SHARE	$	-		$	-		$	-		$	-
WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING
WEIGHTED AVERAGE NUMBER OF SHARES OF COMMON STOCK OUTSTANDING
- BASIC AND DILUTED		79,~~989~~250,~~011~~000			5,000,000			8,622,951			5,000,000

See accompanying notes to the condensed financial statements

TRENTON ACQUISITION CORP.

CONDENSED STATEMENTS OF CASH FLOWS

(Unaudited)

	Three Months Ended			Three Months Ended
	Six Months Ended			Six Months Ended
	June 30, 2017			June 30, 2016
	September 30, 2017			September 30, 2016
CASH FLOWS FROM OPERATING ACTIVITIES:
Net Loss	$	(4178,~~195~~841	)	$	(1026,~~676~~828	)
Adjustment to reconcile net loss to net cash used in operating activities:
Net cash used in Operating Activities		(78,841	)		(26,828	)
Increase in accounts payable and accrued expenses		4,000			3,676
Net cash used in Operating Activities		(37,195	)		(7,000	)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from loans payable – related parties		3782,000			1025,000
Net cash provided by Financing Activities		3782,000			1025,000
Net increase (decrease) in cash		~~(195~~3,159	)		3(1,~~000~~828	)
Cash, at beginning of period		692			2,082
Cash, at end of period	$	~~497~~3,851		$	~~5,082~~254
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION
NON-CASH FINANCING ACTIVITIES:
Conversion of loan payable - related party to common stock	$	85,000		$	-

See accompanying notes to the condensed financial statements

TRENTON ACQUISITION CORP.

NOTES TO CONDENSED FINANCIAL STATEMENTS

Note 1 -

Organization and Business

Business Activity

Trenton Acquisition Corp. (“the Company”) was incorporated in the state of Delaware on January 18, 2011 with the objective to acquire, or merge with, an operating business.

The Company was organized as a vehicle to investigate and, if such investigation warrants, acquire a target company or business seeking the perceived advantages of being a publicly traded corporation. The Company’s principal business objective over the next twelve months and beyond will be to achieve long-term growth potential through a combination with a business, rather than immediate short-term earnings. The Company will not restrict its potential target companies to any specific business, industry, or geographical location. The analysis of business opportunities will be undertaken by, or under the supervision of, the officers and directors of the Company.

On September 11, 2017, the Company, Intrommune Merger Sub LLC, a Delaware limited liability company that is wholly-owned by the Company (“Merger Sub”), and ZENII LLC d/b/a Intrommune Therapeutics (“Intrommune”), a New York limited liability company, entered into an Agreement and Plan of Merger (the “Merger Agreement”) pursuant to which, among other things, subject to the satisfaction or waiver of the conditions set forth in the Merger Agreement, Intrommune will merge with and into Merger Sub and the separate existence of Intrommune will cease and Merger Sub will continue as the surviving entity, wholly-owned by the Company (the “Merger”). Intrommune is a biopharmaceutical company developing an oral mucosal immunotherapy platform for the treatment of food allergies. The Merger is intended to qualify for federal income tax purposes as a tax-free reorganization under the provisions of Section 368(a) of the Internal Revenue Code of 1986, as amended.

Subject to the terms and conditions of the Merger Agreement, at the closing of the Merger (the “Closing”), (a) the officers of the Company will resign and the officers of Intrommune will be appointed officers of the surviving entity; (b) all of the issued and outstanding membership units of Intrommune (the “Intrommune Units”) immediately prior to the Closing will automatically be converted into and exchangeable for such number of shares of the Company’s common stock representing a minimum of 50.5% and a maximum of 58.5% of the issued and outstanding shares of the Company’s capital stock, on a fully diluted basis, depending on the amount of the gross proceeds raised in the Qualified Financing (defined below); and (c) each outstanding option, warrant or other right to purchase Intrommune Units or any other outstanding security convertible into or exchangeable for Intrommune Units will be automatically cancelled.

Consummation of the Merger is subject to the condition that the Company shall have consummated, or be in a position to consummate simultaneously with the Merger, a private placement of Company common stock yielding gross proceeds to the Company of not less than $6 million and not more than $10 million (the “Qualified Financing”), as well as other customary closing conditions. The Merger is expected to close in the quarter ending December 31, 2017.

Change in Control Transaction

On June 30, 2016, the Board of Directors of the Company (the “Board”) appointed Zvi Ben-Zvi to the positions of President and sole director of the Company to fill the vacancies in those positions due to the resignation of Arnold P. Kling.

On August 8, 2016, the Board appointed Kenneth J. Kirsch to the position of Chief Financial Officer of the Company to fill the vacancy in that position due to the resignation of Thomas Pinou.

Note 1 -

Organization and Business (cont’d.)

On April 28, 2017, Rodman & Co., LLC (“Rodman”) purchased Rodman & Renshaw Conference LLC’s $15,000 loan to the Company. Subsequently, on the same day, Rodman converted the entire aggregate loan balance of $85,000 into 4,250,000 shares of the Company’s common stock. As a result of this transaction, the sole member of Rodman was deemed to beneficially own 7,500,000 shares of the Company’s common stock, representing 81% of the Company’s issued and outstanding shares and, as a result, has the ability to control the operations of the Company.

On April 28, 2017, Rodman transferred its entire ownership position, 7,500,000 shares, to Cutter Mill Capital LLC (“Cutter Mill”). Rodman is the sole member of Cutter Mill.

On August 29, 2017, the Board appointed Kenneth J. Kirsch to the additional positions of President and sole director of the Company to fill the vacancies in those positions due to the resignation of Zvi Ben-Zvi.

Note 2 -

Summary of Significant Accounting Policies

Basis of Presentation

The accompanying unaudited condensed financial statements of the Company have been prepared in accordance with accounting ~~principles~~ principles generally accepted in the United States of America (“GAAP”) and the rules and regulations of the Securities and Exchange Commission including Form 10-Q and Regulation S-X. Certain information and footnote disclosure normally present in annual financial statements prepared in accordance with GAAP have been omitted pursuant to such rules and regulations. In the opinion of management, all adjustments considered necessary for a fair presentation of the interim periods presented have been included. All such adjustments are of a normal recurring nature. The accompanying condensed financial statements ~~and the information included under the heading Management’s Discussion and Analysis of Financial Condition and Results of Operations~~ should be read in conjunction with the Company’s audited financial statements and related notes included in the Company’s Form 10-K as of March 31, 2017. Interim results are not necessarily indicative of the results for a full year.

TRENTON ACQUISITION CORP.

NOTES TO CONDENSED FINANCIAL STATEMENTS

Note 2 - Summary of Significant Accounting Policies (cont’d.)

Use of Estimates

The preparation of condensed financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the condensed financial statements and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from those estimates.

Cash Equivalents

The Company considers highly liquid financial instruments purchased with a maturity of three months or less to be cash equivalents. There are no cash equivalents at the condensed balance sheet dates.

Income Taxes

The Company utilizes the accrual method of accounting for income taxes. Under the accrual method, deferred tax assets and liabilities are determined based on the differences between the financial reporting basis and the tax basis of the assets and liabilities and are measured using enacted tax rates and laws that will be in effect when the differences are expected to reverse. An allowance against deferred tax assets is recognized when it is more likely than not that such tax benefits will not be realized.

The Company recognizes the financial statement benefit of an uncertain tax position only after considering the probability that a tax authority would sustain the position upon examination. For tax positions meeting a “more-likely than-not” threshold, the amount recognized in the condensed financial statements is the benefit expected to be realized upon settlement with the tax authority. For tax positions not meeting the threshold, no financial statement benefit is recognized. The Company recognizes interest and penalties, if any, related to uncertain tax positions in income tax expense. As of June 30, 2017 and March 31, 2017, the Company has no accrued interest or penalties related to uncertain tax positions.

Loss Per Common Share

Basic loss per share is calculated using the weighted-average number of common shares outstanding during each reporting period. Diluted loss per share includes potentially dilutive securities such as outstanding options and warrants, using various methods such as the treasury stock or modified treasury stock method in the determination of dilutive shares outstanding during each reporting period. The Company does not have any potentially dilutive instruments for either of the periods presented.

Emerging Growth Company

The Company is an “emerging growth company” and has elected to use the extended transition period for complying with new or revised accounting standards under Section 102(b)(1) of the JOBS Act. This election allows the Company to delay the adoption of new or revised accounting standards that have different effective dates for public and private companies until those standards apply to private companies.

TRENTON ACQUISITION CORP.

NOTES TO CONDENSED FINANCIAL STATEMENTS

Note 2 -

Summary of Significant Accounting Policies (cont’d.)

The Company recognizes the financial statement benefit of an uncertain tax position only after considering the probability that a tax authority would sustain the position upon examination. For tax positions meeting a “more-likely than-not” threshold, the amount recognized in the condensed financial statements is the benefit expected to be realized upon settlement with the tax authority. For tax positions not meeting the threshold, no financial statement benefit is recognized. The Company recognizes interest and penalties, if any, related to uncertain tax positions in income tax expense. As of September 30, 2017 and March 31, 2017, the Company has no accrued interest or penalties related to uncertain tax positions.

Loss Per Common Share

Emerging Growth Company

Recent Accounting Pronouncements

Management does not believe that any recently issued but not yet effective accounting pronouncements, if adopted, would have a material effect on the accompanying condensed financial statements.

Note 3 -

Going Concern

The accompanying condensed financial statements have been prepared assuming the Company will continue as a going concern, which contemplates the recoverability of assets and the satisfaction of liabilities in the normal course of business. The Company has incurred losses from inception of approximately $~~256~~294,000, and has negative working capital of approximately $4178,000 at ~~June~~September 30, 2017,. ~~which~~Management believes ~~among~~these ~~other~~ factors ~~raises~~ raise substantial doubt about the Company’s ability to continue as a going concern. ~~The~~for ~~ability of~~ the ~~Company to continue~~twelve asmonths afollowing ~~going~~the ~~concern~~date isthese ~~dependent~~condensed ~~upon~~financial ~~management’s~~statements ~~plan~~are toissued. ~~find~~Management aintends ~~suitable~~to ~~acquisition~~finance oroperations ~~merger~~over ~~candidate,~~the ~~raise additional~~next ~~capital~~twelve ~~from~~months ~~the~~through ~~sales of stock, and receive~~ additional ~~loans~~borrowings from related parties. ~~The accompanying condensed financial statements do not include any adjustments that might be required should the Company be unable to continue as a going concern.~~

Note 4 - Income Taxes

As of June 30, 2017, the Company has net operating loss carryforwards of approximately $256,000, subject to certain change of control limitations, to reduce future federal and state taxable income through 2036.

The Company currently has no federal or state tax examinations in progress nor has it had any federal or state examinations since its inception. All of the Company’s tax years are subject to federal and state tax examination.

TRENTON ACQUISITION CORP.

NOTES TO CONDENSED FINANCIAL STATEMENTS

Note 4 - Income Taxes ~~(cont’d.)~~

As of September 30, 2017, the Company has net operating loss carryforwards of approximately $294,000, subject to certain change of control limitations, to reduce future federal and state taxable income through 2036, which results in a deferred tax asset of approximately $100,000 against which a full valuation allowance has been recorded.

The benefit from income taxes consists of the following:

	For The Three Months Ended June 30, 2017			For The Three Months Ended June 30, 2016
	For The Six Months Ended September 30, 2017			For The Six Months Ended September 30, 2016
Current Expense:
Federal and state	$	-0		$	-0
Deferred tax benefit:
Federal and state		1427,000			49,000
Valuation allowance		(1427,000	)		(49,000	)
Total	$	-0		$	-0

The benefit from income taxes differs from the amount computed by applying the federal statutory income tax rate to the loss before income taxes due to the following:

	For The Three Months Ended June 30, 2017			For The Three Months Ended June 30, 2016
	For The Six Months Ended September 30, 2017			For The Six Months Ended September 30, 2016
Statutory federal income tax rate		(34	)%		(34	)%
Valuation allowance		34	%		34	%
Effective income tax rate		0	%		0	%

Note 5 -

Common Stock

The Company is authorized to issue one hundred million (100,000,000) shares of $.0001 par value common stock, of which nine million two hundred fifty (9,250,000) shares have been issued. On April 28, 2017, the Company issued 4,250,000 shares of common stock in exchange for the loan payable to related party totaling $85,000.

Note 6 -

Preferred Stock

The Company is authorized to issue ten million (10,000,000) shares of $.0001 par value preferred stock with designations, voting, and other rights and preferences as may be determined from time to time by the Board of Directors of the Company, of which none are issued.

Note 7 -

Related Party Transactions

The Company utilizes the office space and equipment of its management at no cost.

Loan Payable - related party consists of amounts advanced to the Company by Cutter Mill Capital LLC, the Company’s parent. The total loan balance of $3782,000 at ~~June~~ September 30, 2017 is unsecured, noninterest-bearing, and has no stipulated repayment terms.

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

Forward Looking Statement Notice

Certain ~~statements~~ statements made in this Quarterly Report on Form 10-Q are “forward-looking statements” (within the meaning of the Private Securities Litigation Reform Act of 1995) regarding the plans and objectives of management for future operations. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements of Trenton Acquisition Corp. (“we”, “us”, “our” or the “Company”) to be materially ~~different~~ different from any future results, performance or achievements expressed or implied by such forward-looking statements. The forward-looking statements included herein are based on current expectations that involve numerous risks and uncertainties. The Company’s plans and objectives are based, in part, on assumptions involving the continued expansion of business. Assumptions relating to the foregoing involve judgments with respect to, among other things, future economic, competitive and market conditions and future business decisions, all of which are difficult or impossible to predict accurately and many of which are beyond the control of the Company. Although the Company believes its assumptions underlying the forward-looking statements are reasonable, any of the assumptions could prove inaccurate and, therefore, there can be no assurance the forward-looking statements included in this Quarterly Report will prove to be accurate. In light of the significant uncertainties inherent in the forward-looking statements included herein, the inclusion of such information should not be regarded as a representation by the Company or any other person that the objectives and plans of the Company will be achieved.

Description of Business

The Company was incorporated in the State of Delaware on January 18, 2011 (Inception) and maintains its principal executive office at 430 Park Avenue, 4th Floor, New York, NY 10022. Since inception, the Company has been engaged in organizational efforts and obtaining initial financing. The Company was formed as a vehicle to pursue a business combination through the acquisition of, or merger with, an operating business. The Company filed a registration statement on Form 10 with the U.S. Securities and Exchange Commission (the “SEC”) on August 12, 2011, and since its effectiveness, the Company has focused its efforts to identify a possible business combination.

The Company is currently considered to be a “blank check” company. The SEC defines those companies as “any development ~~stage~~ stage company that is issuing a penny stock, within the meaning of Section 3(a)(51) of the Securities Exchange Act of 1934, as ~~amended~~ amended (the “Exchange Act”), and that has no specific business plan or purpose, or has indicated that its business plan is to merge with an unidentified company or companies.” Many states have enacted statutes, rules and regulations limiting ~~the~~ the sale of securities of “blank check” companies in their respective jurisdictions. The Company is also a “shell company,” defined in Rule 12b-2 under the Exchange Act as a company with no or nominal assets (other than cash) and no or nominal operations. Management does not intend to undertake any efforts to cause a market to develop in our securities, either debt or equity, until we have successfully concluded a business combination. The Company intends to comply with the periodic reporting requirements of the Exchange Act for so long as we are subject to those requirements.

In addition, the Company is an “emerging growth company”, as defined in the Jumpstart Our Business Startups Act of 2012 (“JOBS Act”), and may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not “emerging growth companies” including, but not limited to, not being required to comply with the auditor attestation requirements of section 404(b) of the Sarbanes-Oxley Act, and exemptions from the requirements of Sections 14A(a) and (b) of the Exchange Act to hold a nonbinding advisory vote of ~~shareholders~~stockholders on executive compensation and any golden parachute payments not previously approved.

The Company has also elected to use the extended transition period for complying with new or revised accounting standards under Section 102(b)(1) of the JOBS Act. This election allows us to delay the adoption of new or revised accounting standards that have different ~~effective~~ effective dates for public and private companies until those standards apply to private companies. As a result of this election, our financial statements may not be comparable to companies that comply with public company effective dates.

We will remain an “emerging growth company” until the earliest of (1) the last day of the fiscal year during which our revenues exceed $1.07 billion, (2) the date on which we issue more than $1 billion in non-convertible debt in a three year period, (3) the last day of the fiscal year following the fifth anniversary of the date of the first sale of our common equity securities pursuant to an effective registration statement filed pursuant to the Securities Act of 1933, as amended, or (4) when the market value of our common stock that is held by non-affiliates exceeds $700 million as of the last business day of our most recently ~~completed~~ completed second fiscal quarter. To the extent that we continue to qualify as a “smaller reporting company”, as such term is defined in Rule 12b-2 under the Exchange Act, after we cease to qualify as an emerging growth company, certain of the exemptions available to us as an emerging growth company may continue to be available to us as a smaller reporting company, including: (1) not being required to comply with the auditor attestation requirements of Section 404(b) of the Sarbanes Oxley Act; (2) scaled executive compensation disclosures; and (3) the requirement to provide only two years of audited financial statements, ~~instead~~ instead of three years.

We were organized as a vehicle to investigate and, if such investigation warrants, acquire a target company or business seeking the perceived advantages of being a publicly held corporation. Our principal business objective for the next 12 months and beyond such time will be to achieve long-term growth potential through a combination with a business rather than immediate, short-term earnings. We will not restrict our potential candidate target companies to any specific business, industry or geographical location and, thus, may acquire any type of business.

We currently do not engage in any business activities that provide cash flow. During the next twelve months we anticipate ~~incurring~~ incurring costs related to:

(i) filing Exchange Act reports, and

(ii) investigating, analyzing and consummating an acquisition.

We believe we will be able to meet these costs through use of funds in our treasury, through deferral of fees by certain service providers and additional amounts, as necessary, to be loaned to or invested in us by our stockholders, management or other investors. As of the date of the period covered by this report, the Company had $~~497~~3,851 in cash. There are no assurances that the Company will be able to secure any additional funding as needed. Currently, however our ability to continue as a going concern is dependent upon our ability to generate future profitable operations and/or to obtain the necessary financing to meet our obligations and repay our liabilities arising from normal business operations when they come due. Our ability to continue as a going concern is also dependent on our ability to find a suitable target company and enter into a possible reverse merger with such company. Management’s plan includes obtaining additional funds by equity financing through a reverse merger transaction and/or related party advances, however there is no assurance of additional funding being available.

The Company may consider acquiring a business which has recently commenced operations, is a developing company in need of additional funds for expansion into new products or markets, is seeking to develop a new product or service, or is an established business which may be experiencing financial or operating difficulties and is in need of additional capital. In the alternative, a business ~~combination~~ combination may involve the acquisition of, or merger with, a company which does not need substantial additional capital but which ~~desires~~ desires to establish a public trading market for its shares while avoiding, among other things, the time delays, significant expense, ~~and~~ and loss of voting control which may occur in a public offering.

Any target business that is selected may be a financially unstable company or an entity in its early stages of development or growth, including entities without established records of sales or earnings. In that event, we will be subject to numerous risks inherent in the business and operations of financially unstable and early stage or potential emerging growth companies. In addition, we may effect a business combination with an entity in an industry characterized by a high level of risk, and, although our management will endeavor to evaluate the risks inherent in a particular target business, there can be no assurance that we will properly ascertain or assess all significant risks. Our management anticipates that it will likely be able to effect only one business combination, due primarily to our limited financing and the dilution of interest for present and prospective stockholders, which is likely to occur as a result of our management’s plan to offer a controlling interest to a target business in order to achieve a tax-free reorganization. This lack of diversification should be considered a substantial risk in investing in us, because it will not permit us to offset potential losses from one venture against gains from another.

The Company anticipates that the selection of a business combination will be complex and extremely risky. Our management believes that there are numerous firms seeking the perceived benefits of becoming a publicly traded corporation. Such perceived benefits of becoming a publicly traded corporation include, among other things, facilitating or improving the terms on which additional equity financing may be obtained, providing liquidity for the principals of and investors in a business, creating a means for providing incentive stock options or similar benefits to key employees, and offering greater flexibility in structuring acquisitions, joint ventures and the like through the issuance of stock. Potentially available business combinations may occur in many different industries and at various stages of development, all of which will make the task of comparative investigation and analysis of such business opportunities extremely difficult and complex.

~~Liquidity~~On September 11, 2017, the Company, Intrommune Merger Sub LLC, a Delaware limited liability company that is wholly-owned by the Company (“Merger Sub”), and ~~Capital~~ZENII ~~Resources~~LLC d/b/a Intrommune Therapeutics (“Intrommune”), a New York limited liability company, entered into an Agreement and Plan of Merger (the “Merger Agreement”) pursuant to which, among other things, subject to the satisfaction or waiver of the conditions set forth in the Merger Agreement, Intrommune will merge with and into Merger Sub and the separate existence of Intrommune will cease and Merger Sub will continue as the surviving entity, wholly-owned by the Company (the “Merger”). Intrommune is a biopharmaceutical company developing an oral mucosal immunotherapy platform for the treatment of food allergies. The Merger is intended to qualify for federal income tax purposes as a tax-free reorganization under the provisions of Section 368(a) of the Internal Revenue Code of 1986, as amended.

AsSubject to the terms and conditions of ~~June~~the ~~30,~~Merger ~~2017~~Agreement, ~~we had~~at ~~total~~the ~~assets~~closing of ~~$497~~the Merger (the “Closing”), ~~comprised~~(a) ~~exclusively~~the officers of ~~cash,~~the Company ~~compared~~will ~~with~~resign ~~total~~and ~~assets~~the officers of ~~$692~~Intrommune aswill be appointed officers of ~~March~~the ~~31,~~surviving ~~2017,~~entity; ~~also~~(b) ~~comprised exclusively~~all of ~~cash. As~~the ofissued ~~June~~and outstanding ~~30,~~membership ~~2017,~~units weof ~~had~~Intrommune ~~total~~(the ~~current~~“Intrommune ~~liabilities~~Units”) ~~equal~~immediately prior to ~~$41,000,~~the ~~comprised~~Closing ofwill ~~accounts~~automatically ~~payable~~be converted into and ~~accrued~~exchangeable ~~expenses,~~for such number of shares of the Company’s common stock representing a minimum of 50.5% and ~~loan~~a ~~payable~~maximum toof ~~related~~58.5% ~~party~~of ~~compared~~the toissued ~~total~~and ~~current~~outstanding ~~liabilities~~shares of ~~$85~~the Company’s capital stock,~~000~~ ason ofa ~~March~~fully 31diluted basis, depending ~~2017,~~on ~~comprised~~the amount of ~~loan~~the ~~payable~~gross toproceeds ~~related~~raised ~~party.~~in Wethe ~~provide~~Qualified noFinancing ~~assurance~~(defined ~~that~~below); weand ~~can~~(c) ~~continue~~each outstanding option, warrant or other right to ~~satisfy~~purchase ~~our~~Intrommune ~~cash~~Units ~~requirements for~~or atany ~~least~~other ~~the~~outstanding ~~next~~security 12convertible ~~months~~into or exchangeable for Intrommune Units will be automatically cancelled.

~~The~~Consummation of ~~following~~the Merger is subject to the condition that the Company shall have consummated, or be in a ~~summary~~position to consummate simultaneously with the Merger, a private placement of Company common stock yielding gross proceeds to the Company’s ~~cash~~of ~~flows~~not ~~provided~~less bythan $6 million and not more than $10 million (~~used~~the ~~in)~~“Qualified ~~operating~~Financing”), ~~investing,~~as ~~and~~well ~~financing~~as ~~activities:~~other customary closing conditions. The Merger is expected to close in the quarter ending December 31, 2017.

	Three Months Ended June 30, 2017			Three Months Ended June 30, 2016
Net Cash Used in Operating Activities	$	(37,195	)	$	(7,000	)
Net Cash Used in Investing Activities		-			-
Net Cash Provided by Financing Activities		37,000			10,000
Net Increase (Decrease) in Cash and Cash Equivalents	$	(195	)	$	3,000

10Liquidity and Capital Resources

~~The~~As of September 30, ~~Company~~2017, ~~has~~we ~~only~~had ~~cash~~total assets ~~and~~of ~~has~~$3,851, ~~generated~~comprised noexclusively ~~revenues~~of ~~since~~cash, ~~inception.~~compared ~~The~~with ~~Company~~total isassets ~~also~~of ~~dependent~~$692 ~~upon~~as ~~the~~of ~~receipt~~March of31, 2017, also ~~capital~~comprised ~~investment~~exclusively orof ~~other~~cash. As ~~financing~~of toSeptember ~~fund~~30, ~~its~~2017, ~~ongoing~~we ~~operations~~had ~~and~~total tocurrent ~~execute~~liabilities ~~its~~equal ~~business~~to ~~plan~~$82,000, comprised of ~~seeking~~accounts apayable ~~combination with~~and aaccrued ~~private~~expenses, ~~operating~~and ~~company.~~loan Inpayable ~~addition,~~to ~~the~~related ~~Company~~party iscompared ~~dependent~~to ~~upon~~total ~~certain~~current ~~related~~liabilities ~~parties~~of to$85,000 ~~provide~~as of ~~continued~~March ~~funding and~~31, ~~capital~~2017, ~~resources.~~comprised Ifof ~~continued~~loan ~~funding~~payable ~~and~~to ~~capital~~related ~~resources~~party. ~~are~~We ~~unavailable~~provide atno ~~reasonable~~assurance ~~terms,~~that ~~the~~we ~~Company~~can ~~may~~continue ~~not~~to besatisfy our cash ~~able~~requirements tofor ~~implement~~at ~~its~~least ~~plan~~the ofnext ~~operations~~12 months.

~~Results~~The following is a summary of ~~Operations~~the Company’s cash flows provided by (used in) operating, investing, and financing activities:

The Company has not conducted any active operations since inception, except for its efforts to locate suitable acquisition candidates. No revenue has been generated by the Company from January 18, 2011 (Inception), through June 30, 2017. It is unlikely the Company will have any revenues unless it is able to effect an acquisition or merger with an operating company, of which there can be no assurance. It is management’s assertion that these circumstances may hinder the Company’s ability to continue as a going concern. The Company’s plan of operation for the next 12 months shall be to continue its efforts to locate suitable acquisition candidates.

	Six Months Ended September 30, 2017			Six Months Ended September 30, 2016
Net Cash Used in Operating Activities	$	(78,841	)	$	(26,828	)
Net Cash Used in Investing Activities		-			-
Net Cash Provided by Financing Activities		82,000			25,000
Net Increase (Decrease) in Cash and Cash Equivalents	$	3,159		$	(1,828	)

~~For~~The ~~the~~Company ~~three~~has only ~~months~~cash ~~ended June~~assets ~~30,~~and ~~2017,~~has ~~the~~generated no revenues since inception. The Company ~~had~~is aalso ~~net~~dependent ~~loss~~upon the receipt of ~~$41,195~~capital ~~comprised~~investment or ofother ~~legal,~~financing ~~accounting,~~to ~~audit~~fund its ongoing operations and ~~other~~to ~~professional~~execute ~~service~~its ~~fees incurred~~business inplan ~~connection~~of seeking a combination with ~~the~~a ~~preparation~~private ~~and~~operating company. ~~filing~~In ofaddition, the Company’s ~~periodic~~is ~~reports~~dependent ~~and~~upon ~~investigating~~certain arelated ~~potential~~parties ~~business combination~~to ~~transaction,~~provide continued funding and ~~general~~capital resources. If continued funding and ~~administrative~~capital ~~expenses~~resources are unavailable at reasonable terms, the Company may not be able to implement its plan of operations.

~~For~~Results ~~the three months ended June 30, 2016, the Company had a net loss~~ of $10,676 comprised of legal, accounting, audit and other professional service fees incurred in connection with the preparation and filing of the Company’s periodic reports and general and administrative expenses.Operations

~~Off-Balance~~The Company has not conducted any active operations since ~~Sheet~~inception, ~~Arrangements~~except for its efforts to locate suitable acquisition candidates. No revenue has been generated by the Company from January 18, 2011 (Inception), through September 30, 2017. It is unlikely the Company will have any revenues unless it is able to effect an acquisition or merger with an operating company, of which there can be no assurance. It is management’s assertion that these circumstances may hinder the Company’s ability to continue as a going concern. The Company’s plan of operation for the next 12 months shall be to continue its efforts to locate suitable acquisition candidates.

~~The Company~~For ~~does~~the ~~not~~three ~~have~~and ~~any~~six ~~off-balance~~months ~~sheet~~ended ~~arrangements~~September ~~that~~30, ~~have~~2017, orthe Company ~~are~~had ~~reasonably~~a ~~likely~~net toloss ~~have~~of a$37,646 ~~current~~and or$78,841, ~~future~~respectively, ~~effect on~~comprised ~~the~~of ~~Company’s~~legal, ~~financial condition~~accounting, ~~changes~~audit and other professional service fees incurred in ~~financial~~connection ~~condition,~~with ~~revenues~~the orpreparation ~~expenses,~~and ~~results~~filing of ~~operations,~~the ~~liquidity~~Company’s periodic reports, ~~capital~~ ~~expenditures~~expenses orrelated ~~capital~~to ~~resources~~the ~~that~~aforementioned Merger isand ~~material~~general toand ~~investors~~administrative expenses.

11For the three and six months ended September 30, 2016, the Company had a net loss of $16,152 and $26,828, respectively, comprised of legal, accounting, audit and other professional service fees incurred in connection with the preparation and filing of the Company’s periodic reports, and general and administrative expenses

~~Item 3.~~Off-Balance ~~Quantitative~~Sheet ~~and Qualitative Disclosures About Market Risk.~~Arrangements

AsThe Company does anot ~~“smaller~~have ~~reporting~~any ~~company”~~off-balance assheet ~~defined~~arrangements bythat ~~Item~~have 10or ofare ~~Regulation~~reasonably ~~S-K,~~likely to have a current or future effect on the Company’s financial iscondition, ~~not~~changes ~~required~~in tofinancial ~~provide~~condition, ~~the~~revenues or expenses, results of operations, liquidity, capital expenditures ~~information~~or ~~required~~capital byresources ~~this~~that ~~Item~~is material to investors.

~~Item 4. Controls and Procedures.~~11

~~Evaluation of~~Item ~~Disclosure~~3. ~~Controls~~Quantitative and ~~Procedures~~Qualitative Disclosures About Market Risk.

~~We maintain~~As ~~disclosure~~a ~~controls~~“smaller ~~and~~reporting ~~procedures that are designed to ensure that information required to be disclosed in our reports~~company” ~~filed~~as ~~pursuant~~defined toby ~~the~~Item ~~Exchange~~10 ~~Act~~ of ~~1934,~~Regulation ~~as amended~~S-K, ~~is recorded, processed, summarized and reported within~~ the ~~time~~Company ~~periods specified in the SEC’s rules, regulations and related forms, and that such information~~ is ~~accumulated~~not ~~and~~required ~~communicated~~ to ~~our~~ ~~principal~~provide ~~executive~~the ~~officer~~information ~~and~~required ~~principal~~by ~~financial~~this ~~officer, as appropriate, to allow timely decisions regarding required disclosure~~Item.

~~As of~~Item June 30, 2017, we carried out an evaluation, under the supervision and with the participation of our principal executive officer and our principal financial officer of the effectiveness of the design and operation of our disclosure controls and procedures4. ~~Based~~ onControls ~~this evaluation, our principal executive officer~~ and ~~our principal financial officer concluded that our disclosure controls and procedures were effective as of the end of the period covered by this report~~Procedures.

~~Changes in~~Evaluation ~~Internal~~of Disclosure Controls and Procedures

~~There~~We maintain disclosure ~~have~~controls ~~been~~and noprocedures ~~changes~~that are designed to ensure that information required to be disclosed in our ~~internal~~reports ~~controls~~filed ~~over~~pursuant ~~financial~~to the ~~reporting~~Exchange ~~during~~Act ~~the~~of ~~quarter~~1934, ~~ended~~as ~~June~~amended, 30is recorded, ~~2017~~processed, ~~that~~summarized ~~have~~and ~~materially~~reported within the time periods specified in the ~~affected~~SEC’s orrules, ~~are~~regulations ~~reasonably~~and ~~likely~~related toforms, ~~materially~~and ~~affect~~that such information is accumulated and communicated to our ~~internal~~principal ~~controls~~executive officer ~~over~~and principal financial ~~reporting~~officer, as appropriate, to allow timely decisions regarding required disclosure.

~~PART~~As of September II30, -2017, ~~OTHER~~we ~~INFORMATION~~carried out an evaluation, under the supervision and with the participation of our principal executive officer and our principal financial officer of the effectiveness of the design and operation of our disclosure controls and procedures. Based on this evaluation, our principal executive officer and our principal financial officer concluded that our disclosure controls and procedures were effective as of the end of the period covered by this report.

~~Item 1.~~Changes ~~Legal~~in ~~Proceedings.~~Internal Controls

There ~~are~~ ~~presently~~have been no ~~material~~changes ~~pending~~in ~~legal~~our ~~proceedings~~internal tocontrols ~~which~~over ~~the~~financial ~~Company,~~reporting ~~any~~during ofthe ~~its~~quarter ~~subsidiaries,~~ended ~~any~~September ~~executive officer~~30, ~~any owner~~2017 ofthat ~~record~~have ormaterially ~~beneficially of more than five percent of any class of voting securities is a party~~ affected or ~~as to which any of its property is subject, and no such proceedings~~ are ~~known~~reasonably likely to ~~the~~materially ~~Company~~affect toour beinternal ~~threatened~~controls orover ~~contemplated~~financial ~~against it~~reporting.

~~Item 1A.~~PART ~~Risk~~II ~~Factors.~~- OTHER INFORMATION

~~As a “smaller reporting company” as defined by~~ Item 101. ofLegal ~~Regulation S-K, the Company is not required to provide the information required by this Item~~Proceedings.

~~Item~~There are presently 2.no ~~Unregistered~~material ~~Sales~~pending legal proceedings to which the Company, any of ~~Equity~~its ~~Securities~~subsidiaries, ~~and~~any ~~Use~~executive officer, any owner of ~~Proceeds~~record or beneficially of more than five percent of any class of voting securities is a party or as to which any of its property is subject, and no such proceedings are known to the Company to be threatened or contemplated against it.

~~On April~~Item ~~28, 2017, Rodman & Co~~1A., ~~LLC~~Risk ~~(“Rodman”) purchased Rodman & Renshaw Conferences, LLC’s loan to us~~Factors. Subsequently, on the same day, Rodman converted the entire aggregate loan balance of $85,000 into 4,250,000 shares of our common stock. The issuance of these shares was exempt from the registration requirements of the Securities Act of 1933, as amended, in reliance on Sections 4(a)(2) and 4(a)(6) thereunder and an appropriate restrictive legend was imprinted on the stock certificate.

~~Item~~As a “smaller 3.reporting ~~Defaults~~company” ~~Upon~~as ~~Senior~~defined ~~Securities~~by Item 10 of Regulation S-K, the Company is not required to provide the information required by this Item.

~~None~~Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

~~Item 4~~None. ~~Mine Safety Disclosures.~~

~~Not applicable~~Item 3. Defaults Upon Senior Securities.

~~Item 5~~None. ~~Other Information.~~

~~None~~Item 4. Mine Safety Disclosures.

12Not applicable.

Item 6 5. ~~Exhibits~~Other Information.

Exhibit No.		Description
31.1		Chief Executive Officer Certification pursuant to section 302 of the Sarbanes-Oxley Act of 2002
31.2		Chief Financial Officer Certification pursuant to section 302 of the Sarbanes-Oxley Act of 2002
32.1		Chief Executive Officer Certification pursuant to section 906 of the Sarbanes-Oxley Act of 2002.*
32.2		Chief Financial Officer Certification pursuant to section 906 of the Sarbanes-Oxley Act of 2002.*
101.INS		XBRL Instance Document
101.SCH		XBRL Taxonomy Extension Schema
101.CAL		XBRL Taxonomy Extension Calculation Linkbase
101.DEF		XBRL Taxonomy Extension Definition Linkbase
101.LAB		XBRL Taxonomy Extension Label Linkbase
101.PRE		XBRL Taxonomy Extension Presentation Linkbase

None.

* Furnished, not filed, in accordance with Item 601(32)(ii) of Regulation S-K.12

13Item 6. Exhibits.

SIGNATURES

Exhibit No.		Description

2.1		Agreement and Plan of Merger, dated as of September 11, 2017, by and among Trenton Acquisition Corp., Intrommune Merger Sub LLC and ZENII LLC.(1)

31.1		Certification of the Principal Executive Officer pursuant to section 302 of the Sarbanes-Oxley Act of 2002

31.2		Certification of the Principal Financial Officer pursuant to section 302 of the Sarbanes-Oxley Act of 2002

32.1		Certification of the Principal Executive Officer and Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to section 906 of the Sarbanes-Oxley Act of 2002 *

101.INS		XBRL Instance Document

101.SCH		XBRL Taxonomy Extension Schema

101.CAL		XBRL Taxonomy Extension Calculation Linkbase

101.DEF		XBRL Taxonomy Extension Definition Linkbase

101.LAB		XBRL Taxonomy Extension Label Linkbase

101.PRE		XBRL Taxonomy Extension Presentation Linkbase

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

*	Furnished, not filed, in accordance with Item 601(32)(ii) of Regulation S-K.
(1)	Filed as an exhibit to the Company’s Current Report on Form 8-K, as filed with the SEC on September 13, 2017, and incorporated herein by this reference.

	Trenton Acquisition Corp.
Dated: August 14, 2017	By:	/s/ Zvi Ben-Zvi
		Zvi Ben-Zvi President (Principal Executive Officer)
Dated: August 14, 2017	By:	/s/ Kenneth J. Kirsch
		Kenneth J. Kirsch Chief Financial Officer, (Principal Financial Officer)

14SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	Trenton Acquisition Corp.

Dated: October 19, 2017	By:	/s/ Kenneth J. Kirsch
		Kenneth J. Kirsch President and Chief Financial Officer (Principal Executive and Financial Officer)

Filing Compare · Trenton Acquisition Corp.